Could a simple steroid taper cut opioid use after ACL surgery?
NCT ID NCT07605923
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a short course of the steroid methylprednisolone to standard pain medicine can reduce the need for strong narcotic painkillers after ACL knee surgery. About 64 people aged 14 to 65 will be randomly assigned to get either the steroid plus standard care, or standard care alone. Researchers will track pain levels, medication use, and recovery of knee motion for three months after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL RECONSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Osteoporosis drug could strengthen knee rebuilds
- Blood flow cuffs or instrument massage: which boosts ACL recovery best?
- Simple hop test could predict ACL Re-Injury risk
- Can adding motion release to blood flow training boost ACL healing?
- Does an extra knee ligament procedure lead to arthritis later?
- Mind over knee: mental skills training may boost ACL recovery in young athletes